6 results
Diffuse large B cell lymphoma (DLBCL) - Management and Treatment Algorithm

By Matthew Ho, MD PhD @MatthewHoMD

#Diffuse
(DLBCL) - Management ... and Treatment Algorithm ... #DLBCL #Management ... #Treatment #Algorithm ... #oncology #hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... for VTE in Malignancy ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
Tumor Lysis Syndrome
An acute, life-threatening condition that appears within 7 days of starting cytotoxic therapies in
chemosensitive malignancy ... like Burkitt's lymphoma ... Walid Malki, MD, MS ... Syndrome #TLS #oncology ... #management #UricAcid
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
Hodgkin's Lymphoma ... hematological malignancy ... Treatment • Early ... classification #hematology ... #oncology #management
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
phenomenon (16%) MSK ... Arthralgia and Arthritis ... Malignancy Risk ... Adenocarcinoma Treatment ... #Diagnosis #Management